Live news related to SANOFI stock (FR0000120578): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
Sanofi's stock experienced a sharp decline this Thursday morning, dropping 4.71% to 78.67 euros amid changes at the helm of the pharmaceutical group. …
The Board of Directors of Sanofi has decided not to renew the mandate of Paul Hudson and has appointed Belén Garijo as the CEO. Belén Garijo will assu…
On February 10, 2026, Sanofi announced the completion of the acquisition of Dynavax Technologies Corporation, in accordance with the terms of the tend…
Sanofi shares increased by 1.78% this Tuesday morning, February 10, reaching 81.72 euros. This rebound follows the announcement of a major designation…
The FDA has granted rilzabrutinib (Wayrilz) a breakthrough therapy designation for warm antibody autoimmune hemolytic anemia, while Japan has granted …
HSBC ajuste sa position sur Sanofi ce mercredi 4 février 2026.
Sanofi's stock shows an increase of 1.36% to 80.28 euros this Monday, February 2, 2026, at mid-session, driven by the announcement of a major clinical…
Sanofi announces that venglustat has met all primary endpoints in the LEAP2MONO phase 3 study for type 3 Gaucher's disease. The company will proceed w…
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended conditional marketing authorization for San…
Sanofi shares increased by 1.66% this Friday, January 30, 2026, in the late afternoon, reaching 78.36 euros. This rebound follows the publication of s…
